|
EPR Archived News |
COVANCE INCREASES ITS PHASE I CLINICAL CAPACITY WITH ACQUISITION OF GFI RESEARCH CENTERReleased on = August 30, 2005, 6:40 pm Press Release Author = Covance Inc. Industry = Pharmaceuticals Press Release
Summary = COVANCE INCREASES ITS PHASE I CLINICAL CAPACITY WITH ACQUISITION
OF GFI RESEARCH CENTER Press Release
Body = COVANCE INCREASES ITS PHASE I CLINICAL CAPACITY WITH ACQUISITION
OF GFI RESEARCH CENTER Covance acquired the assets of the Evansville, Indiana-based clinical research unit for $5.7 million. The 80-bed facility will now be part of Covance Clinical Research Unit Inc., and will be known as Covance GFI Research. "Covance
has been looking to expand its clinical pharmacology presence in
North America and GFI helps fill that need with a high quality asset,"
says Covance CEO Joe Herring. "With continued high demand in
the clinical pharmacology market, we're pleased to have found a
CRU with similar expertise and reputation in handling "The purchase is welcome news to GFI and its 100 employees," remarks Christi Bradley, MBA, RD, Vice President and General Manager of GFI Clinical Services. "We're very excited about being a part of Covance, as well as the prospect of growing and enhancing our clinical capabilities." About Covance Statements contained
in this press release, which are not historical facts, are forward-looking
statements pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. All such forward-looking
statements including the statements contained herein regarding anticipated
trends in the Company's business are based largely on management's
expectations and are subject to Covance and
the Covance logo are registered service marks of Covance in the
United States and other countries. http://www.covance.com. Web Site = http://www.covance.com Contact Details
= Covance Inc.
|
|
2012
